TipRanks
Go Ultimate55% OFF

Arbutus Biopharma (I9DN) Revenue

Arbutus Biopharma Revenue

Arbutus Biopharma had a revenue of 1.01M in the quarter ending Jun 30, 2026, with -99.43%. This bring the company's revenue in the last twelve months to 181.72M, Decreased 5.08%. In the fiscal year ending Dec 31, 2025, Arbutus Biopharma had annual revenue of 14.08M with 128.21% growth.

Revenue (ttm)
181.72M
Revenue Growth
1021.96%
P/S Ratio
52.85
Revenue/Employee
EUR 741,211
Employees
19
Market Cap
EUR 744.29M

Revenue Chart

Arbutus Biopharma Revenue - Annual

010M20M30M40M50M10.70M5.90M6.01M6.91M10.99M39.02M18.14M6.17M14.08M201720182019202020212022202320242025
Revenue History
Download to Excel
DE:I9DN revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202514.08M7.91M128.21%
Dec 31, 20246.17M-11.97M-65.98%
Dec 31, 202318.14M-20.88M-53.51%
Dec 31, 202239.02M28.03M255.11%
Dec 31, 202110.99M4.07M58.92%
Dec 31, 20206.91M903.00K15.02%
Dec 31, 20196.01M111.00K1.88%
Dec 31, 20185.90M-4.80M-44.86%
Dec 31, 201710.70M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:I9DN181.72M
ENTA65.26M
ARCT23.80M
ASMB74.84M
SLN614.29K
AVIR0.00